Skip to main content
. Author manuscript; available in PMC: 2021 Jan 21.
Published in final edited form as: Circ Heart Fail. 2020 Jan 21;13(1):e006389. doi: 10.1161/CIRCHEARTFAILURE.119.006389

Table 2.

Summary of Per-protocol Defined Events (N=19)

Outcome Total (N=27) 1500 mg (N=12) 3000 mg (N=15)
Death 0 0 0
Left ventricular assist device 1 1 0
Heart transplant 0 0 0
Serious adverse events* 2 1 1
All cause hospitalizations
 Total N of hospitalizations 24 8 16
 Patients with hospitalizations 9 5 4
Cardiovascular hospitalizations
 Total N of CV hospitalizations 20 7 13
 Patients with CV hospitalizations 9 5 4
Heart failure (HF) hospitalizations
 Total N of HF hospitalizations 9 2 7
 Patients with HF hospitalizations 4 1 3
*

Systolic blood pressure drop <90 mmHg in the 1500mg arm and creatine increase >0.5 mg/dL in the 3000-mg arm

1 patient had 10 encounters; 8 for cardiovascular reasons and 4 specifically for heart failure